FDA Authorizes 4th & 5th COVID-19 Shots For Americans

COVID-19 mania is like a drug addiction for the medical tyrants of the FDA.

On Tuesday, the federal agency authorized a 4th and 5th COVID-19 shot using the same mRNA formula.

These booster doses are essentially worthless at providing any protection against weakened strains of COVID-19 that compare to the common cold.

Nevertheless, the FDA pushes forward with more mRNA gene therapy insanity.

mRNA madness: FDA authorizes both 4th and 5th COVID shotshttps://t.co/2nVVF8ki6C

— Jordan Schachtel @ dossier.today (@JordanSchachtel) March 29, 2022

BREAKING: FDA authorizes second round of booster shots for everyone over the age of 50—kicking off the regulatory process for shots to likely be available in pharmacies sometime this week. https://t.co/5cPjyaUaoM

— ABC News (@ABC) March 29, 2022

MAJOR UPDATE ON BOOSTERS:

1. 50+ may get 2nd booster FOUR MONTHS after 1st (4th shot)

2. Immunocompromised 12+ can get a 2nd (or 5th shot) after their 4th mRNA

3. J and J no changes

Still nothing re boosters for 5-11

And no vaccine yet for under 5
https://t.co/pBjlkVM23u

— Kavita Patel M.D. (@kavitapmd) March 29, 2022

Per the FDA:

Today, the U.S. Food and Drug Administration authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals. The FDA previously authorized a single booster dose for certain immunocompromised individuals following completion of a three-dose primary vaccination series. This action will now make a second booster dose of these vaccines available to other populations at higher risk for severe disease, hospitalization and death. Emerging evidence suggests that a second booster dose of an mRNA COVID-19 vaccine improves protection against severe COVID-19 and is not associated with new safety concerns.

The agency amended the emergency use authorizations as follows:

• A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine or Moderna COVID-19 Vaccine may be administered to individuals 50 years of age and older at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine.
• A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine may be administered to individuals 12 years of age and older with certain kinds of immunocompromise at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine. These are people who have undergone solid organ transplantation, or who are living with conditions that are considered to have an equivalent level of immunocompromise.
• A second booster dose of the Moderna COVID-19 Vaccine may be administered at least 4 months after the first booster dose of any authorized or approved COVID-19 vaccine to individuals 18 years of age and older with the same certain kinds of immunocompromise.

Independent journalist Jordan Schachtel noted the approval of the 5th dose for immunocompromised individuals in The Dossier:

If you didn’t catch the fifth shot authorization statement initially, that’s because the FDA seems to be delivering its advice in deliberately confusing language. Also, it probably has something to do with our broader corporate press only reporting on select portions of the press release.

Here’s the relevant portion about the fifth dose:

*Source – The Dossier*

For individuals who are considered immunocompromised, the FDA and CDC now define “fully vaccinated” as a “three course primary series” of mRNA shots. But for non-immunocompromised people, “fully vaccinated” currently means two mRNA shots.

The agency said this especially fragile group also can get an additional booster, a fifth shot. https://t.co/CgEcNpJfer

— ABC7 Sarasota (@mysuncoast) March 29, 2022

This action will now make a second booster dose of these vaccines available to other populations at higher risk for severe disease, hospitalization and death.

— U.S. FDA (@US_FDA) March 29, 2022

The Associated Press wrote:

Until now, the FDA had allowed a fourth vaccine dose only for the immune-compromised as young as 12. Tuesday’s decision allows them another booster, too — a fifth dose. Marks said those patients are more likely to see their immune protection wane sooner and therefore can benefit more from extra protection. Only the Pfizer vaccine can be used in those as young as 12; Moderna’s is for adults.